GlobeNewswire
-
Santhera Appoints Marc Clausse as Chief Commercial Officer to Lead Next Phase of Growth
10/03/2026 -
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
10/03/2026 -
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
10/03/2026 -
Nebu Ease Portable Nebulizer Claims Evaluated: 2026 Consumer Research Report on Mesh Nebulizer Technology, Respiratory Comfort Features, and What Buyers Should Verify
10/03/2026 -
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
10/03/2026 -
TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations
09/03/2026 -
Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas
09/03/2026 -
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
09/03/2026 -
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates
09/03/2026 -
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/03/2026 -
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
09/03/2026 -
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/03/2026 -
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
09/03/2026 -
Stereotaxis Reports 2025 Full Year Financial Results
09/03/2026 -
Xenon Pharmaceuticals Announces Proposed Public Offering
09/03/2026 -
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
09/03/2026 -
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
09/03/2026 -
Kristen Boehmer of Empowered Lyfe Partners with MD Logic Health to Launch Daily Colostrum, an Advanced Low Molecular Weight Bioactive Colostrum
09/03/2026 -
MemoTril Consumer Concerns Under Investigation: Critiquing The Memo Tril Claims
09/03/2026
Pages